Publications - PulmoTension

Retrouvez les publications scientifiques majeures relatives à l’hypertension pulmonaire auxquelles les membres des centres de référence et de compétence PulmoTension ont contribué.

Rechercher une publication :

07/2025
Severe Hypoxemia and Pulmonary Capillary Dilatations in Pulmonary Arterial Hypertension Patients Treated with Sotatercept (nouvel onglet)

Olsson KM, Savale L, Guignabert C, Park DH, Kamp JC, Boucly A, Montani D, Sitbon O, Humbert M, Hoeper MM

Am J Respir Crit Care Med. 2025 Jul;211(7):1303-1305. doi: 10.1164/rccm.202502-0344RL. PMID: 40315146
06/2025
Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR) (nouvel onglet)

Montani D, McLaughlin VV, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman AB, Escribano Subias P, Feldman J, Meyer GM, Olsson KM, Coulet F, Manimaran S, Zhao Y, Lau A, de Oliveira Pena J, Badesch DB, Humbert M

Am J Respir Crit Care Med. 2025 Jun;211(6):1028-1037. doi: 10.1164/rccm.202409-1698OC. PMID: 40035659.
06/2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD) (nouvel onglet)

Thoreau B, Renaud A, Chafey P, Clary G, Le Gall M, Broussard C, Launay O, Launay D, Hachulla E, Deligny C, Baruteau AE, Vallet-Pichard A, Chaigne B, Yaici A, Sitbon O, Montani D, Humbert M, Mouthon L

Rheumatology (Oxford). 2025 Jun 1;64(6):4041-4050. doi: 10.1093/rheumatology/keaf075. PMID: 39918970.
05/2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death (nouvel onglet)

Humbert M, McLaughlin VV, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Preston IR, Souza R, Waxman AB, Moles VM, Savale L, Vizza CD, Rosenkranz S, Shi Y, Miller B, Mackenzie HS, Kim SS, Loureiro MJ, Patel MJ, Koglin J, Cornell AG, Hoeper MM; ZENITH Trial Investigators

N Engl J Med. 2025 May 29;392(20):1987-2000. doi: 10.1056/NEJMoa2415160. Epub 2025 Mar 31. PMID: 40167274.
05/2025
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbidities (nouvel onglet)

Boucly A, Montani D, Bauer F, Artaud-Macari E, Bergot E, Boissin C, Chaouat A, Cottin V, Dauphin C, Degano B, De Groote P, du Roure C, Favrolt N, Horeau-Langlard D, Jaïs X, Jevnikar M, Lacoste-Palasset T, Picard F, Prévôt G, Reynaud-Gaubert M, Roche A, Turquier S, Humbert M, Sitbon O, Savale L

Eur Respir J. 2025 May 6;65(5):2400895. doi: 10.1183/13993003.00895-2024. PMID: 39884763.
05/2025
Association of Pulmonary Hypertension With Trastuzumab Emtansine: An Analysis of French Pulmonary Hypertension Registry and WHO Pharmacovigilance Database (nouvel onglet)

Poisson C, Hlavaty A, Favrolt N, Chaumais MC, Grynblat J, Jutant EM, Lechartier B, Maurac A, Mouillot P, Palat S, Rambach L, Antigny F, Cottin V, Beltramo G, Humbert M, Khouri C, Bonniaud P, Montani D

Chest. 2025 May;167(5):1468-1480. doi: 10.1016/j.chest.2024.11.006. Epub 2024 Nov 19. PMID: 39571726.
05/2025
Risk stratification in Eisenmenger syndrome (nouvel onglet)

Valdeolmillos E, Boucly A, Humbert M, Sitbon O, Savale L, Montani D, Le Pavec J, Fadel E, Ladouceur M, Fournier E, Albenque G, Provost B, Batteux C, Fraisse A, Gatzoulis MA, Kempny A, Hascoët S

Arch Cardiovasc Dis. 2025 May;118(5):322-329. doi: 10.1016/j.acvd.2025.02.010. Epub 2025 Mar 28. PMID: 40204597.
03/2025
Pulmonary hypertension in patients carrying FLNA loss-of-function variants (nouvel onglet)

Stourm L, Grynblat J, Savale L, Lacoste-Palasset T, Jaïs X, Coulet F, Levy M, Meyrignac O, Ghigna MR, Cottin V, Sitbon O, Bonnet D, Goupil F, Humbert M, Gagnadoux F, Montani D; French PH Network PULMOTENSION Investigators

Eur Respir J. 2025 Mar 6;65(3):2401132. doi: 10.1183/13993003.01132-2024. PMID: 39510553.
02/2025
Impact of BMPR2 mutation on the severity of pulmonary arterial hypertension: a systematic review and meta-analysis (nouvel onglet)

Wu J, Huang Q, Zhang Y, De Z, Fu H, Zhan Y, Gu Y, Xie J

Respir Res. 2025 Feb 28;26(1):74. doi: 10.1186/s12931-025-03145-5. PMID: 40022182; PMCID: PMC11871596
02/2025
Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in CTEPH: Insights From the RACE Trial (nouvel onglet)

Gerges C, Jevnikar M, Brenot P, Savale L, Beurnier A, Bouvaist H, Sitbon O, Fadel E, Boucly A, Chemla D, Simonneau G, Humbert M, Montani D, Jaïs X; RACE Investigators

Circ Cardiovasc Interv. 2025 Feb;18(2):e014785. doi: 10.1161/CIRCINTERVENTIONS.124.014785. Epub 2025 Feb 18. PMID: 39965044.

Rechercher une publication :

Severe Hypoxemia and Pulmonary Capillary Dilatations in Pulmonary Arterial Hypertension Patients Treated with Sotatercept (nouvel onglet)

Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR) (nouvel onglet)

Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD) (nouvel onglet)

Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death (nouvel onglet)

Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbidities (nouvel onglet)

Association of Pulmonary Hypertension With Trastuzumab Emtansine: An Analysis of French Pulmonary Hypertension Registry and WHO Pharmacovigilance Database (nouvel onglet)

Risk stratification in Eisenmenger syndrome (nouvel onglet)

Pulmonary hypertension in patients carrying FLNA loss-of-function variants (nouvel onglet)

Impact of BMPR2 mutation on the severity of pulmonary arterial hypertension: a systematic review and meta-analysis (nouvel onglet)

Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in CTEPH: Insights From the RACE Trial (nouvel onglet)